A Liquid Biopsy-based Assay Could Detect Recurrence Prior to Imaging in Patients With Resectable Colorectal Cancer
April 28, 2025
April 28, 2025
PHILADELPHIA, Pennsylvania, April 28 [Category: Medical] -- The American Association for Cancer Research posted the following news release:
* * *
A Liquid Biopsy-based Assay Could Detect Recurrence Prior to Imaging in Patients With Resectable Colorectal Cancer
CHICAGO - An ultrasensitive circulating tumor DNA (ctDNA)-based liquid biopsy assay detected signs of recurrence prior to imaging and provided prognostic value within one month after surgery in patien . . .
* * *
A Liquid Biopsy-based Assay Could Detect Recurrence Prior to Imaging in Patients With Resectable Colorectal Cancer
CHICAGO - An ultrasensitive circulating tumor DNA (ctDNA)-based liquid biopsy assay detected signs of recurrence prior to imaging and provided prognostic value within one month after surgery in patien . . .
